Quarter Financials
Axsome Therapeutics, Inc. (AXSM)
$62.44
+0.93 (+1.51%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -61 | -45 | -41 | -40 | -34 | -35 | -32 | -29 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -596 | -535 | -490 | -449 | -409 | -375 | -340 | -308 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -0 | -0 | -0 | -0 | - | -0 | -0 | -0 |
|---|
| Net PPE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | 12 | 12 | 10 |
|---|